<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">rsp</journal-id><journal-title-group><journal-title xml:lang="ru">Научно-практическая ревматология</journal-title><trans-title-group xml:lang="en"><trans-title>Rheumatology Science and Practice</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1995-4484</issn><issn pub-type="epub">1995-4492</issn><publisher><publisher-name>IMA-PRESS, LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.47360/1995-4484-2022-481-486</article-id><article-id custom-type="elpub" pub-id-type="custom">rsp-3203</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL RESEARCH</subject></subj-group></article-categories><title-group><article-title>Частота инфицированности Helicobacter pylori больных ревматоидным артритом и взрослых жителей города Тулы</article-title><trans-title-group xml:lang="en"><trans-title>The frequency of Helicobacter pylori infection in patients with rheumatoid arthritis and adult residents of the city of Tula</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3014-9370</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Плахова</surname><given-names>А. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Plakhova</surname><given-names>A. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>300012, Тула, проспект Ленина, 92 </p></bio><bio xml:lang="en"><p>300012, Tula, Lenina avenue, 92 </p></bio><email xlink:type="simple">Angela.Alieva.89@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3684-7310</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сороцкая</surname><given-names>В. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Sorotskaya</surname><given-names>V. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>300012, Тула, проспект Ленина, 92 </p></bio><bio xml:lang="en"><p>300012, Tula, Lenina avenue, 92 </p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1550-8213</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Балабанова</surname><given-names>Р. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Balabanova</surname><given-names>R. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>115522, Москва, Каширское шоссе, 34а</p></bio><bio xml:lang="en"><p>115522, Moscow, Kashirskoye Highway, 34A</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">ФГБОУ ВО «Тульский государственный университет»<country>Россия</country></aff><aff xml:lang="en">Tula State University<country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru">ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»<country>Россия</country></aff><aff xml:lang="en">V.A. Nasonova Research Institute of Rheumatology<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>07</day><month>09</month><year>2022</year></pub-date><volume>60</volume><issue>4</issue><fpage>481</fpage><lpage>486</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Плахова А.О., Сороцкая В.Н., Балабанова Р.М., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Плахова А.О., Сороцкая В.Н., Балабанова Р.М.</copyright-holder><copyright-holder xml:lang="en">Plakhova A.O., Sorotskaya V.N., Balabanova R.M.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://rsp.mediar-press.net/rsp/article/view/3203">https://rsp.mediar-press.net/rsp/article/view/3203</self-uri><abstract><p>В настоящее время продолжает пополняться список микроорганизмов, имеющих возможную связь с развитием ревматоидного артрита (РА). Активно изучается роль не только традиционных патогенов, но и представителей условно-патогенной микрофлоры. Ряд отечественных и зарубежных работ демонстрируют высокую степень инфицированности Helicobacter pylori (H. pylori) больных ревматическими заболеваниями (РЗ) и в том числе РА.</p><p>Цель работы – выявить частоту обнаружения Helicobacter pylori у больных ревматоидным артритом и у взрослых жителей города Тулы без ревматических заболеваний.</p><sec><title>Материал и методы</title><p>Материал и методы. В исследование включены 3288 жителей г. Тулы, не имеющих РЗ, и 119 пациентов с РА. Для выявления инфекции у пациентов без РЗ использовались дыхательный аммиачный тест, серологический метод и выполнявшаяся по общепринятой методике фиброэзофагогастродуоденоскопия (ФЭГДС) с биопсией слизистой оболочки антрального отдела и тела желудка и последующей верификацией H. pylori с помощью тест-системы Хелпил-тест (ООО «АМА», Россия). Все больные РА обследовались с помощью ФЭГДС.</p></sec><sec><title>Результаты</title><p>Результаты. При обследовании жителей г. Тулы без РЗ (n=3288) наибольший процент инфицированных (78,8%) выявлен с помощью экспресс-диагностики уреазной активности биоптата. Частота выявления инфекции с помощью дыхательного аммиачного теста и серологического метода оказалась ниже и составила 51,1 и 49,3% соответственно. Всего H. pylori выявлена у 1692 (51,46%) пациентов без РЗ. Она также обнаружена у 81,5% больных РА. Часто выявлялись признаки поражения слизистой оболочки верхних отделов желудочно-кишечного тракта (ЖКТ): поверхностный и субатрофический гастрит, единичные эрозии.</p></sec><sec><title>Выводы</title><p>Выводы. 1. В настоящем исследовании установлено, что инфицированность H. pylori у больных РА находится на достаточно высоком уровне, статистически значимо не отличаясь от таковой у пациентов без РЗ по данным экспресс-диагностики уреазной активности биоптата (81,5 и 78,8% соответственно). 2. Среди больных РА отмечено увеличение частоты инфицированности с возрастом (р&lt;0,05). 3. Частота выявления эрозивно-язвенного поражения ЖКТ у инфицированных H. pylori больных РА была статистически значимо выше, чем у неинфицированных (соответственно 42,2 и 13,6%; р=0,03). Ключевые слова: население г. Тулы, ревматоидный артрит, инфекция Helicobacter pylori&gt;˂ 0,05). 3. Частота выявления эрозивно-язвенного поражения ЖКТ у инфицированных H. pylori больных РА была статистически значимо выше, чем у неинфицированных (соответственно 42,2 и 13,6%; р=0,03). </p></sec></abstract><trans-abstract xml:lang="en"><p>Currently, the list of microorganisms that have a possible connection with the development of rheumatoid arthritis continues to be updated. The role of not only traditional pathogens, but also representatives of conditionally pathogenic microflora is being actively studied. A number of domestic and foreign works demonstrate a high degree of Helicobacter pylori infection in patients with rheumatic diseases, including rheumatoid arthritis.</p><p>The aim of the present study is to identify the frequency of detection of Helicobacter pylori infection in patients with rheumatoid arthritis and in adult residents of the city of Tula.</p><sec><title>Material and methods</title><p>Material and methods. The study included 3288 residents of Tula who do not have rheumatic diseases, and 119 patients with rheumatoid arthritis. To detect the infection, FEGDS was performed according to the generally accepted method with the taking of biopsies of the mucous membrane of the antrum and the stomach body, followed by verification of Helicobacter pylori using the Helpil-test test system.</p></sec><sec><title>Results</title><p>Results. According to the results of the data on the infection rate of residents of Tula without rheumatic diseases (n=3288), the largest percentage of infected (78.8%) was detected by an invasive method – express diagnosis of urease activity of the biopsy. The detection rate using a respiratory ammonia test and serological method was lower and amounted to 51.1 and 49.3%, respectively. In total, H. pylori was detected in 1692 people, which was 51.46%. Among patients with rheumatoid arthritis, Helicobacter pylori infection was 81.5%. Signs of damage to the mucous membrane of the upper gastrointestinal tract were often detected: superficial and subatrophic gastritis, single erosions.</p></sec><sec><title>Conclusions</title><p>Conclusions. 1. Based on the study, it was found that the infection rate of Helicobacter pylori in patients with rheumatoid arthritis is at a fairly high level, not significantly different from that in residents without rheumatic diseases, when examined by an invasive method – express diagnosis of urease activity of the biopsy (81.5% and 78.8%, respectively). 2. Among patients with rheumatoid arthritis, there was a tendency to increase the frequency of infection with age and peak values in older age groups (r=0.37; p&lt;0.05). 3. The frequency of detection of erosive and ulcerative lesions of the gastrointestinal tract in infected and uninfected Helicobacter pylori patients with rheumatoid arthritis significantly differed (42.2 and 13.6%) (p=0.03). Key words: Tula population, rheumatoid arthritis, Helicobacter pylori infection&gt;˂ 0.05). 3. The frequency of detection of erosive and ulcerative lesions of the gastrointestinal tract in infected and uninfected Helicobacter pylori patients with rheumatoid arthritis significantly differed (42.2 and 13.6%) (p=0.03). </p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>население г. Тулы</kwd><kwd>ревматоидный артрит</kwd><kwd>инфекция Helicobacter pylori</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Tula population</kwd><kwd>rheumatoid arthritis</kwd><kwd>Helicobacter pylori infection</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Насонов ЕЛ. Прогресс ревматологии в начале XXI века. Современная ревматология. 2014;(3):4-8. doi: 10.14412/1996-7012-2014- 3-4-8</mixed-citation><mixed-citation xml:lang="en">Nasonov EL. Progress in rheumatology in the early 21st century. Modern Rheumatology Journal. 2014;(3):4-8 (In Russ.). doi: 10.14412/1996-7012-2014- 3-4-8</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Сороцкая ВН. Анализ летальных исходов вследствие инфекционных осложнений при ревматических заболеваниях в Тульской области за период 1996–2000 годы. Научно-практическая ревматология. 2004;42(2):65-67.</mixed-citation><mixed-citation xml:lang="en">Sorotskaya VN. Analysis of lethal outcomes due to infectious complications in rheumatic diseases in Tula region in 1996–2000. NauchnoPrakticheskaya Revmatologia = Rheumatology Science and Practice. 2004;42(2):65-67 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Балабанова РМ. Ревматические заболевания и вирусная инфекция: есть ли связь? Современная ревматология. 2020;14(4):98-102. doi: 10.14412/1996-7012-2020-4-98-102</mixed-citation><mixed-citation xml:lang="en">Balabanova RM. Rheumatic diseases and viral infection: is there an association? Modern Rheumatology Journal. 2020;14(4):98-102 (In Russ.). doi: 10.14412/1996-7012-2020-4-98-102</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Белянская НЭ, Абдулганиева ДИ. Особенности патологии верхних отделов желудочно-кишечного тракта у больных ревматоидным артритом. Вестник современной клинической медицины. 2009;2(2):15a-17.</mixed-citation><mixed-citation xml:lang="en">Belyanskaya NE, Abdoulganiyeva DI. Pathology of upper gastrointestinal tract in patients with rheumatoid arthritis Vestnik sovremennoy klinicheskoy meditsiny. 2009;2(2):15a-17 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Youssefi M, Tafaghodi M, Farsiani H, Ghazvini K, Keikha M. Helicobacter pylori infection and autoimmune diseases; Is there an association with systemic lupus erythematosus, rheumatoid arthritis, autoimmune atrophy gastritis and autoimmune pancreatitis? A systematic review and meta-analysis study. J Microbiol Immunol Infect. 2021;54(3):359-369. doi: 10.1016/j.jmii.2020.08.011</mixed-citation><mixed-citation xml:lang="en">Youssefi M, Tafaghodi M, Farsiani H, Ghazvini K, Keikha M. Helicobacter pylori infection and autoimmune diseases; Is there an association with systemic lupus erythematosus, rheumatoid arthritis, autoimmune atrophy gastritis and autoimmune pancreatitis? A systematic review and meta-analysis study. J Microbiol Immunol Infect. 2021;54(3):359-369. doi: 10.1016/j.jmii.2020.08.011</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Каратеев АЕ, Цурган АВ, Мороз ЕВ. Helicobacter pylori у больных ревматическими заболеваниями: частота инфицированности и оценка эффективности альтернативной схемы эрадикационной терапии. Русский медицинский журнал. 2017;(17): 1220-1224.</mixed-citation><mixed-citation xml:lang="en">Karateev AE, Tsurgan AV, Moroz EV. Helicobacter pylori in patients with rheumatic diseases: The incidence of infection and evaluation of the effectiveness of the alternative scheme of eradication therapy. RMJ. 2017;(17):1220-1224 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Гадиева ШФ, Мусаев СК. Влияние клинико-иммунологических параметров на частоту и степень распространенности Helicobacter pylori у больных ревматоидным артритом. Научнопрактическая ревматология. 2017;55(6):634-636. doi: 10.14412/1995-4484-2017-634-636</mixed-citation><mixed-citation xml:lang="en">Gadieva SF, Musaev SK. Impact of clinical and immunological parameters on the frequency and prevalence of Helicobacter pylori in patients with rheumatoid arthritis. Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2017;55(6):634-636 (In Russ.). doi: 10.14412/1995-4484-2017-634-636</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Subhash VV, Ho B. Inflammation and proliferation – a causal event of host response to Helicobacter pylori infection. Microbiology (Reading). 2015;161(6):1150-1160. doi: 10.1099/mic.0.000066</mixed-citation><mixed-citation xml:lang="en">Subhash VV, Ho B. Inflammation and proliferation – a causal event of host response to Helicobacter pylori infection. Microbiology (Reading). 2015;161(6):1150-1160. doi: 10.1099/mic.0.000066</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Radić M, Kaliterna DM, Bonacin D, Vergles JM, Radić J, Fabijanić D, et al. Is Helicobacter pylori infection a risk factor for disease severity in systemic sclerosis? Rheumatol Int. 2013;33(11):2943-2948. doi: 10.1007/s00296-012-2585-z</mixed-citation><mixed-citation xml:lang="en">Radić M, Kaliterna DM, Bonacin D, Vergles JM, Radić J, Fabijanić D, et al. Is Helicobacter pylori infection a risk factor for disease severity in systemic sclerosis? Rheumatol Int. 2013;33(11):2943-2948. doi: 10.1007/s00296-012-2585-z</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Маев ИВ, Самсонов АА, Андреев ДН. Инфекция Helicobacter pylori. М.:ГЭОТАР-Медиа;2016.</mixed-citation><mixed-citation xml:lang="en">Mayev IV, Samsonov AA, Andreev DN. Helicobacter pylori infection. Moscow:GEOTARMedia;2016 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Сварваль АВ, Ферман РС, Жебрун АБ. Распространен - ность инфекции Helicobacter pylori среди населения Северо-Западного федерального округа Российской Федерации. Журнал микробиологии, эпидемиологии и иммунобиологии. 2011;(4):84-88.</mixed-citation><mixed-citation xml:lang="en">Svarval AV, Ferman RS, Zhebrun AB. Prevalence of Helicobater pylori infection among population of Northwestern Federal District of Russian Federation. Journal of Microbiology, Epidemiology and Immunobiology. 2011;(4):84-88 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Бордин ДС, Плавник РГ, Невмержицкий ВИ, Буторова ЛИ, Абдулхаков РА, Абдулхаков СР, и др. Распространенность Helicobacter pylori среди медицинских работников Москвы и Казани по данным ¹³С-уреазного дыхательного теста. Альманах клинической медицины. 2018;46(1):40-49. doi: 10.18786/2072-0505-2018-46-1-40-49</mixed-citation><mixed-citation xml:lang="en">Bordin DS, Plavnik RG, Nevmerzhitskiy VI, Butorova LI, Abdulkhakov RA, Abdulkhakov SR, et al. Prevalence of Helicobacter pylori among medical workers in Moscow and Kazan according to ¹³С-urease breath test. Almanac of Clinical Medicine. 2018;46(1):40-49 (In Russ.). doi: 10.18786/2072-0505-2018-46-1-40-49</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Жесткова ТВ, Бутов МА, Лымарь ЮЮ, Папков СВ. Распространенность инфекции Helicobacter pylori среди жителей Рязанского региона. Российский медико-биологический вестник имени академика И.П. Павлова. 2019;27(1):35-40. doi: 10.23888/PAVLOVJ201927135-40</mixed-citation><mixed-citation xml:lang="en">Zhestkova TV, Butov MA, Lymar YuYu, Papkov S.V. Prevalence rate of Helicobacter pylori infection among population of Ryazan Region. I.P. Pavlov Russian Medical Biological Herald. 2019;27(1):35- 40 (In Russ.). doi: 10.23888/PAVLOVJ201927135-40</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Жесткова ТВ, Бутов МА, Папков СВ. Распространенность инфекции Helicobacter pylori у городского населения. Терапевтический архив. 2018;90(4):17-20. doi: 10.26442/terarkh201890417-20</mixed-citation><mixed-citation xml:lang="en">Zhestkova TV, Butov MA, Papkov SV. The prevalence of Helicobacter pylori infection among urban population. Terapevticheskii arkhiv. 2018;90(4):17-20 (In Russ.). doi: 10.26442/terarkh201890417-20</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Маев ИВ, Самсонов АА, Андреев ДН, Гречушников ВБ, Коровина ТИ. Клиническое значение инфекции Helicobacter pylori. Клиническая медицина. 2013;91(8):4-12.</mixed-citation><mixed-citation xml:lang="en">Maev IV, Samsonov AA, Andreev DN, Grechushnikov VB, Korovina TI. Clinical significance of Helicobacter pylori infection. Clinical Medicine. 2013;91(8):4-12 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Wen H, Luo J, Li J, Li X. Helicobacter pylori infection in rheumatic diseases. Arthritis Res Ther. 2012;14(Suppl 1):74. doi: 10.1186/ar3675</mixed-citation><mixed-citation xml:lang="en">Wen H, Luo J, Li J, Li X. Helicobacter pylori infection in rheumatic diseases. Arthritis Res Ther. 2012;14(Suppl 1):74. doi: 10.1186/ar3675</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Yula E, Köksal F. Autoimmune extraintestinal manifestations of Helicobacter pylori infection: A bundle of conflicts. J Immunol Clin Microbiol. 2016;1(1):22-30. doi: 10.5455/jicm.10.20160627</mixed-citation><mixed-citation xml:lang="en">Yula E, Köksal F. Autoimmune extraintestinal manifestations of Helicobacter pylori infection: A bundle of conflicts. J Immunol Clin Microbiol. 2016;1(1):22-30. doi: 10.5455/jicm.10.20160627</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Kulhar A, Sharma H. Prevalence of Helicobacter pylori in patients of rheumatoid arthritis with upper gastrointestinal symptoms. Int J Sci Res. 2019;8(1):42-44. doi: 10.36106/ijsr</mixed-citation><mixed-citation xml:lang="en">Kulhar A, Sharma H. Prevalence of Helicobacter pylori in patients of rheumatoid arthritis with upper gastrointestinal symptoms. Int J Sci Res. 2019;8(1):42-44. doi: 10.36106/ijsr</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Goggin PM, Collins DA, Jazrawi RP, Jackson PA, Corbishley CM, Bourke BE, et al. Prevalence of Helicobacter pylori infection and its effect on symptoms and non-steroidal antiinflammatory drug induced gastrointestinal damage in patients with rheumatoid arthritis. Gut. 1993;34(12):1677-1680. doi: 10.1136/gut.34.12.1677</mixed-citation><mixed-citation xml:lang="en">Goggin PM, Collins DA, Jazrawi RP, Jackson PA, Corbishley CM, Bourke BE, et al. Prevalence of Helicobacter pylori infection and its effect on symptoms and non-steroidal antiinflammatory drug induced gastrointestinal damage in patients with rheumatoid arthritis. Gut. 1993;34(12):1677-1680. doi: 10.1136/gut.34.12.1677</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Насонова ВА, Каратеев АЕ. Распространенность, структура и факторы риска развития гастропатий, индуцированных нестероидными противовоспалительными препаратами. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2000;10(4):274-276.</mixed-citation><mixed-citation xml:lang="en">Nasonova VA, Karateev AE. Prevalence, structure and risk factors for the development of gastropathies induced by nonsteroidal anti-inflammatory drugs. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2000;10(4):274-276 (In Russ.).</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
